Old Web
English
Sign In
Acemap
>
authorDetail
>
Jonathan T. Bliggenstorfer
Jonathan T. Bliggenstorfer
University Hospitals of Cleveland
Medicine
survival outcome
Internal medicine
Oncology
Systemic therapy
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Improved survival supports primary endocrine therapy in patients with hormone receptor positive/ HER-2 negative metastatic breast cancer.
2021
Journal of Clinical Oncology
Robert Shenk
Lifen Cao
Jonathan T. Bliggenstorfer
James Michael Martin
Megan E. Miller
Show All
Source
Cite
Save
Citations (0)
Surgery provides survival benefit over systemic therapy alone for stage IV triple negative breast cancer: A propensity matched analysis of the National Cancer Database.
2021
Journal of Clinical Oncology
Lifen Cao
Jonathan T. Bliggenstorfer
Kavin Sugumar
Christopher W. Towe
Pamela Li
Lisa Rock
Robert Shenk
James Michael Martin
Megan E. Miller
Show All
Source
Cite
Save
Citations (0)
Metastatic site-specific utilization and outcome of immunotherapy in stage IV melanoma: A national perspective.
2021
Journal of Clinical Oncology
Lifen Cao
Jonathan T. Bliggenstorfer
Christopher W. Towe
Ankit Mangla
Megan E. Miller
Luke D. Rothermel
Show All
Source
Cite
Save
Citations (0)
1